JANX NASDAQ
Janux Therapeutics, Inc.
1W: +0.1%
1M: -6.4%
3M: +10.2%
YTD: +5.6%
1Y: -43.3%
3Y: +25.0%
$14.52
+0.11 (+0.76%)
Weekly Expected Move ±4.2%
$13
$13
$14
$14
$15
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$22M
Revenue
+131.5% YoY
$-114M
Net Income
-47.3% YoY
$-78M
Free Cash Flow
-68.7% YoY
87.4%
Gross Margin
-916.5%
Op. Margin
-652.6%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-11.6%
ROA-11.1%
ROIC-1000.6%
Valuation
P/E-7.9
P/B1.0
EV/EBITDA0.5
Leverage
Debt/Equity0.02
Current Ratio39.04
Interest Cov.0.0x
Quality Scores
Piotroski F2/9
Altman Z11.90
Beneish M0.00